A very large diversity space of synthetically accessible compounds for use with drug design programs. - Sergey Nikitin; Natalia Zaitseva; Olga Demina; Vera Solovieva; Evgeny Mazin; Sergey Mikhalev; Maxim Smolov; Anatoliy Rubinov; Peter Vlasov; Dmitry Lepikhin; Denis Khachko; Valery Fokin; et al. (J. Comput. Aided Mol. Des., 2005)

Quantitative Structure-Price Relationship (QS$R) Modeling and the Development of Economically Feasible Drug Discovery Projects. - Michael Fernández; Fuqiang Ban; Godwin Woo; Olexandr Isayev; Carl Perez; Valery Fokin; Alexander Tropsha; Artem Cherkasov (J. Chem. Inf. Model., 2019)